30 September 2026

Équipe Body Expert

6 min de lecture

Hair transplants and antidepressants: should you stop your medication?

A man with thinning hair holds his bowed head in his hands, with pills and an open bottle on the table in front of him.

Do not stop or reduce an antidepressant yourself to prepare for a hair transplant. Taking this medication does not automatically rule out surgery. Many patients taking a selective serotonin reuptake inhibitor, or SSRI, can continue treatment with appropriate precautions. The decision depends on the particular medicine, your health and the planned procedure.

Two separate questions need answering: could the medicine be contributing to your hair loss, and does it change the precautions needed during surgery? Your prescriber and the transplant team should assess these together.

A person in a black top faces a professional holding a pen, with a form, a red stethoscope and two amber bottles on the table.

Can antidepressants cause hair loss?

Hair loss has been reported with some antidepressants, including SSRIs. A 2022 systematic review brought together 38 publications describing 71 patients and 81 episodes of hair loss associated with these medicines. It confirms that cases have been reported, but cannot tell us what proportion of all users will experience hair loss. Published case reports do not provide that population-wide denominator.

The reported time to onset varied considerably. Shedding may begin after treatment starts or a dose changes, but that sequence alone does not establish that the medicine caused it.

Drug-related shedding can take the form of telogen effluvium: more hairs enter the resting phase of the growth cycle and subsequently shed. The thinning is generally diffuse, rather than confined to the temples or crown. Improvement may follow an adjustment agreed with the prescriber, but it is not necessarily immediate or guaranteed. Shedding settling down and visible density recovering are different stages.

Two open hands hold long, loose strands of hair against a light background.

A case report describing improvement within a few weeks therefore cannot provide a timetable for your own recovery. Nor does a suspected side effect justify abruptly withdrawing a treatment that is helping you.

Establish the diagnosis before planning a transplant

A dermatologist assesses the pattern of hair loss, scalp findings and changes over time. These are considered alongside the dates of medication changes, recent illness, significant stress and other medical factors. Further investigations may be appropriate, but not everyone needs the same set of tests.

Potentially reversible diffuse shedding needs to be distinguished from androgenetic alopecia and other scalp disorders. More than one process can occur at the same time: an episode of shedding may make existing pattern hair loss more noticeable. Our guide to types of alopecia explains these distinctions.

Blue-gloved hands rest on the scalp of a man with short, sparse hair and his head bowed.

A transplant redistributes existing follicles. It does not remove the cause of active telogen effluvium and is generally not the first response to hair loss that may recover. If the diagnosis remains uncertain, clarifying it should come before settling on a graft count or an operation date.

Minoxidil or finasteride should not automatically be started to compensate for suspected medication-related shedding. Any hair-loss treatment should match the diagnosis and be assessed for its own expected benefits and risks.

A woman in a white coat examines the scalp of a man with sparse hair using a handheld optical device.

Why can stopping suddenly be a problem?

Abruptly stopping, reducing a dose too quickly or missing doses can cause withdrawal symptoms. These may include dizziness, nausea, disturbed sleep, anxiety, irritability and unusual sensations. Their severity and duration vary; some people experience substantial or prolonged symptoms.

Withdrawal is not the same as a relapse of depression. The two need to be distinguished, even when some symptoms overlap. Stopping treatment may also, separately, increase the risk of the condition it was prescribed for returning.

When stopping is medically appropriate, NICE recommends an individual, gradual reduction with monitoring. This may take weeks or longer. The plan depends on factors such as the medicine, how long it has been taken and how you respond to dose reductions. There is no universal instruction to stop every antidepressant seven days before surgery.

A tablet rests in an open palm, with a clear cup containing water held above it.

An elective cosmetic procedure should fit around that medical decision. If your treatment needs more time to settle, postponing the transplant may be preferable to a rushed medication change.

What needs checking before surgery?

Bleeding risk: figures from other operations are not transplant figures

SSRIs can affect platelets, which help stop bleeding. Observational studies have found an association with bleeding complications in some operations, but results vary according to the procedure, patient population and how bleeding was defined.

Roose and Rutherford’s review emphasises that the available evidence cannot precisely establish an individual patient’s risk for a particular procedure. Figures from orthopaedic, cardiac or breast surgery cannot simply be applied to hair transplantation. Equally, calling a transplant a superficial procedure does not establish that there is no risk.

The team needs to consider any history of bleeding and other medicines, including anticoagulants, aspirin and anti-inflammatory painkillers. Do not stop any of these without appropriate medical instructions.

Interactions with medicines used during and after the procedure

Local anaesthesia does not remove the need for an interaction check. Depending on the protocol, the team may also use sedatives, painkillers or anti-sickness medicines.

The UK Clinical Pharmacy Association’s perioperative handbook generally advises continuing sertraline, while checking interactions and individual risk factors. It identifies precautions with some painkillers, including tramadol, because of the possibility of serotonin toxicity. This does not mean a complication will occur; it means medication choices and monitoring should be planned.

Antidepressants are not interchangeable. Advice about an SSRI cannot automatically be applied to a tricyclic antidepressant, a monoamine oxidase inhibitor or a combination of treatments. Giving the team the exact medicine name is more useful than simply saying that you take an antidepressant.

How should you prepare for the consultation?

Bring an up-to-date list covering:

Each medicine’s name, dose and usual timing, including recent changes.
Non-prescription products, herbal remedies and supplements, including St John’s wort.
Any history of bleeding, reactions to anaesthesia or difficulty stopping a medicine previously.
When the shedding began and how it has changed, with comparable photographs from different dates if available.

Your prescriber assesses the mental-health implications of changing treatment. The surgical team identifies the medicines planned for the procedure and the associated risks. Communication between them should produce one clear plan covering the day of surgery and recovery.

A doctor and a patient wearing a blue sweater look together at an open blue folder in a consultation room.

If a general preparation sheet appears to contradict your prescription, have the discrepancy resolved before travelling. Written instructions for your circumstances help avoid having to choose between conflicting advice yourself.

For treatment abroad, also arrange continuity of your medication, copies of prescriptions and contact details for the clinician who normally treats you. Preparation should cover the return journey and access to advice if symptoms develop.

Will antidepressants affect regrowth after a transplant?

The available sources do not establish a precise graft-failure rate attributable to antidepressants. They also cannot guarantee that any shedding after surgery will be unrelated to medication.

Shedding of transplanted hair shafts can be part of the early postoperative course. Other processes, such as telogen effluvium or progression of existing alopecia, may also contribute to changes in density. Persistent or unusual changes deserve assessment rather than an improvised medication stop. Our hair transplant timeline provides context for follow-up, without replacing that assessment.

If persistent pattern hair loss makes surgery worth considering, the donor area still needs careful examination. Antidepressant treatment is one part of the medical history, not the only factor determining suitability.

Body Expert is a medical tourism agency working with partner clinics for hair transplants in Turkey. The indication for surgery and medication instructions remain clinical decisions. Disclosing your treatment from the first enquiry helps organise that assessment while keeping your hair-restoration goals and ongoing mental-health care in view.

References

Pejcic, A. V., & Paudel, V. (2022). Alopecia associated with the use of selective serotonin reuptake inhibitors: Systematic review. Psychiatry Research, 313, 114620. https://doi.org/10.1016/j.psychres.2022.114620

Roose, S. P., & Rutherford, B. R. (2016). Selective serotonin reuptake inhibitors and operative bleeding risk: A review of the literature. Journal of Clinical Psychopharmacology, 36(6), 704–709. https://doi.org/10.1097/JCP.0000000000000575

UK Clinical Pharmacy Association. (n.d.). Sertraline. Handbook of Perioperative Medicines. Retrieved September 22, 2026. https://periop-handbook.ukclinicalpharmacy.org/drug/sertraline/

National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NG222). Recommendations 1.4.12–1.4.21. https://www.nice.org.uk/guidance/ng222/chapter/Recommendations

NHS. (2025, June 12). Antidepressants. https://www.nhs.uk/medicines/antidepressants/